Wegovy

Wegovy (semaglutide) is a prescription injectable for chronic weight management in adults with obesity or weight-related conditions. It supports appetite regulation and may be prescribed alongside diet and exercise. This overview highlights key considerations for informed use.

Semaglutide, the active ingredient in Wegovy, is prescribed to help adults manage long-term weight by reducing hunger and calorie intake. It is typically used by individuals with a body mass index (BMI) of 30 or higher, or those with a BMI of 27 or higher with weight-related health issues. This medication is intended for use under medical supervision as part of a broader health plan.

Wegovy works by mimicking a hormone that regulates appetite, which may lead to reduced food cravings and gradual weight loss over time. Common effects include changes in appetite and digestion, though individual responses can vary widely. It is not a quick-fix solution and requires consistent use alongside lifestyle adjustments.

Store Wegovy in the refrigerator until first use, then it can be kept at room temperature for a limited time. Keep the pen away from light and avoid freezing. Always check the pen for particles or discoloration before use. Dispose of used needles safely in a sharps container. Consult a healthcare provider if you experience persistent side effects.

Wegovy may interact with medications that affect blood sugar, such as insulin or sulfonylureas, potentially increasing the risk of low blood sugar. It can also slow gastric emptying, which may impact the absorption of other oral medications. Alcohol use may exacerbate side effects like nausea. Always inform your healthcare provider about all medications and supplements you are taking.